547
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effectiveness of tailored talks between a cancer screening specialist and general practitioners to improve the uptake of colorectal cancer screening in Ancona (Italy) during the pandemic period

, , , , , , , , , , & show all
Article: 2340672 | Received 18 Mar 2023, Accepted 02 Apr 2024, Published online: 15 Apr 2024

References

  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
  • von Karsa L, Patnick J, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy. 2013;45(1):51–59.
  • Prime Ministerial Decree January 12th 2017 (Italy). Definition and update of the Essential Assistance Levels (LEA). Ufficial Gazette 65; Rome, March 16th 2017.
  • Zorzi M, Da Re F, Mantellini P, et al. Screening for colorectal cancer in Italy: 2011-2012 survey. Epidemiol Prev. 2015;39(3):1–125.
  • Giorgi Rossi P, Carrozzi G, Falini P, et al. The impact of the COVID-19 pandemic on italian population-based cancer screening activities and test coverage: results from national cross-sectional repeated surveys in 2020. Elife. 2023;12:12. doi: 10.7554/eLife.81804.
  • Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in european countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002–1013. doi: 10.1016/S1470-2045(21)00199-6.
  • Senore C, Basu P, Anttila A, et al. Performance of colorectal cancer screening in the european union member states: data from the second European screening report. Gut. 2019;68(7):1232–1244. doi: 10.1136/gutjnl-2018-317293.
  • Santé Publique. Colorectal cancer: uptake of screening tests stable in 2021–2022. 2024 [cited 2024 March 26]. https://www.santepubliquefrance.fr/les-actualites/2023/cancer-colorectal-un-taux-de-participation-aux-tests-de-depistage-stable-en-2021-2022.
  • Ministerio de S. Colorectal cancer screening programmes. 2024 [cited 2024 March 26]. https://www.sanidad.gob.es/gabinete/notasPrensa.do?metodo=detalle&id=6064.
  • Cancer Research UK. Bowel cancer screening. 2024 [cited 2024 March 26]. https://www.cancerresearchuk.org/health-professional/screening/bowel-cancer-screening#BCOverview1.
  • National Institute for Public Health and the Environment. Monitoring colorectal cancer screening. 2022 [cited 2024 March 26]. https://www.rivm.nl/en/documenten/monitoring-colorectal-cancer-screening-2022.
  • Camilloni L, Ferroni E, Cendales BJ, et al. Methods to increase participation in organised screening programs: a systematic review. BMC Public Health. 2013;13(1):464. doi: 10.1186/1471-2458-13-464.
  • Senore C, Inadomi J, Segnan N, et al. Optimising colorectal cancer screening acceptance: a review. Gut. 2015;64(7):1158–1177. doi: 10.1136/gutjnl-2014-308081.
  • Sabatino SA, Lawrence B, Elder R, et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med. 2012;43(1):97–118. doi: 10.1016/j.amepre.2012.04.009.
  • Walsh JM, Salazar R, Terdiman JP, et al. Promoting use of colorectal cancer screening tests. Can we change physician behavior? J Gen Intern Med. 2005;20(12):1097–1101. doi: 10.1111/j.1525-1497.2005.0245.x.
  • Stracci F, Gili A, Naldini G, et al. Geospatial analysis of the influence of family doctor on colorectal cancer screening adherence. PLOS One. 2019;14(10):e0222396. doi: 10.1371/journal.pone.0222396.
  • Thu-Thon É, Charles R, Froger P, et al. Impact of a general practitioner training program on the colorectal cancer screening participation rate. Sante Publique. 2013; 25(6):775–783. doi: 10.3917/spub.136.0775.
  • Aubin-Auger I, Laouénan C, Le Bel J, et al. Efficacy of communication skills training on colorectal cancer screening by GPs: a cluster randomised controlled trial. Eur J Cancer Care. 2016;25(1):18–26. doi: 10.1111/ecc.12310.
  • Zorzi M, de Bianchi PS, Grazzini G, et al. Quality indicators for the evaluation of colorectal cancer screening programmes. Epidemiol Prev. 2007;31(6 Suppl 1):6–56.
  • Karsa L, Patnick J, Segnan N. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Luxembourg: Publications Office; 2010 [cited 2024 April 3]. https://data.europa.eu/doi/10.2772/1458
  • Federici A, Giorgi Rossi P, Bartolozzi F, et al. The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy). Cancer Causes Control. 2006;17(1):45–52. doi: 10.1007/s10552-005-0380-9.
  • Acuti Martellucci C, Flacco ME, Cappadona R, et al. SARS-CoV-2 pandemic: an overview. Adv Biol Regul. 2020;77:100736. doi: 10.1016/j.jbior.2020.100736.
  • Battisti F, Falini P, Gorini G, et al. Cancer screening programmes in Italy during the COVID-19 pandemic: an update of a nationwide survey on activity volumes and delayed diagnoses. Ann Ist Super Sanita. 2022;58(1):16–24.
  • Acuti Martellucci C, Morettini M, Flacco ME, et al. Delivering cervical cancer screening during the COVID-19 emergency. BMJ Sexual & Reproductive Health. 2021;47(4):296–299.
  • Dodd N, Carey M, Mansfield E, et al. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial. Aust N Z J Public Health. 2019;43(5):464–469. doi: 10.1111/1753-6405.12913.
  • McIntosh JG, Jenkins M, Wood A, et al. Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial. Br J Gen Pract. 2024;74(741):e275–e282. doi: 10.3399/BJGP.2023.0230.
  • Weiss JM, Smith MA, Pickhardt PJ, et al. Predictors of colorectal cancer screening variation among primary-care providers and clinics. Am J Gastroenterol. 2013;108(7):1159–1167. doi: 10.1038/ajg.2013.127.
  • Martellucci CA, Flacco ME, Morettini M, et al. Wide variability in colorectal cancer screening uptake by general practitioner: cross-sectional study. J Med Screen. 2022;29(1):21–25. doi: 10.1177/09691413211035795.
  • Giorgi Rossi P, Carrozzi G, Federici A, et al. Invitation coverage and participation in italian cervical, breast and colorectal cancer screening programmes. J Med Screen. 2018;25(1):17–23. doi: 10.1177/0969141317704476.
  • Hirst Y, Stoffel S, Baio G, et al. Uptake of the English bowel (colorectal) cancer screening programme: an update 5 years after the full roll-out. Eur J Cancer. 2018;103:267–273. doi: 10.1016/j.ejca.2018.07.135.
  • Wang H, Roy S, Kim J, et al. Barriers of colorectal cancer screening in rural USA: a systematic review. Rural Remote Health. 2019;19(3):5181. doi: 10.22605/RRH5181.
  • Goodwin BC, March S, Ireland M, et al. Geographic variation in compliance with Australian colorectal cancer screening programs: the role of attitudinal and cognitive traits. Rural Remote Health. 2019;19(3):4957. doi: 10.22605/RRH4957.
  • Worthington C, McLeish K, Fuller-Thomson E. Adherence over time to cervical cancer screening guidelines: insights from the Canadian national population health survey. J Womens Health. 2012;21(2):199–208. doi: 10.1089/jwh.2010.2090.
  • Worthington J, van Wifferen F, Sun Z, et al. Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening. EClinicalMedicine. 2023;62:102081. doi: 10.1016/j.eclinm.2023.102081.
  • Italian National Institute of Statistics. Istat – Income by municipality, years 2016–2018. Rome; 2020.